Form 8-K - Current report:
SEC Accession No. 0001437749-21-005540
Filing Date
2021-03-10
Accepted
2021-03-10 16:01:56
Documents
3
Period of Report
2021-03-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K dmtp20210310_8k.htm 8-K 24343
2 EXHIBIT 99.1 ex_232960.htm EX-99.1 157374
3 diamedica.jpg GRAPHIC 8966
  Complete submission text file 0001437749-21-005540.txt   195419
Mailing Address 2 CARLSON PARKWAY SUITE 260 MINNEAPOLIS MN 55447
Business Address 2 CARLSON PARKWAY SUITE 260 MINNEAPOLIS MN 55447 (763) 496-5454
DiaMedica Therapeutics Inc. (Filer) CIK: 0001401040 (see all company filings)

EIN.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36291 | Film No.: 21729651
SIC: 2834 Pharmaceutical Preparations